For the Inventor, By the Inventor

Enter assignee name

Jcr Pharmaceuticals Co., Ltd.

Patents = 80

Trademarks = 12

Forward Citations = 220

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

184 inventors (with patents filed for the assignee):

Kenichi Takahashi (17 out of 17 patents)

Hiroyuki Sonoda (12 out of 12 patents)

Susumu Seino (7 out of 13 patents)

4. Takashi Hanada (6 out of 7 patents)

5. Atsushi Sugimura (6 out of 6 patents)

6. Hajime Hiratani (6 out of 18 patents)

7. Miroslav Matev (5 out of 5 patents)

8. Shinji Kakimoto (5 out of 5 patents)

9. Tetsuo Yokoyama (5 out of 5 patents)

10. Kazutoshi Mihara (5 out of 5 patents)

11. Seiji Kikuchi (4 out of 33 patents)

12. Aya Yoshioka (4 out of 4 patents)

13. Hideto Morimoto (4 out of 4 patents)

14. Masafumi Kinoshita (4 out of 4 patents)

15. Yuri Koshimura (4 out of 4 patents)

80 patents: Sort by Forward Citations

1. 12214007 - Fusion protein including BDNF (2025-02-04),

2. 12178858 - Lyophilized preparation (2024-12-31),

3. RE50240 - Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier (2024-12-24),

4. 12145995 - Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier (2024-11-19),

5. 12002210 - Analysis software and apparatus for screening early embryo (2024-06-04),

6. 11958905 - Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody (2024-04-16),

7. 11938464 - Analytical method for sugar chains having acidic groups (2024-03-26),

8. 11932699 - Aqueous pharmaceutical composition (2024-03-19),

9. 11738068 - Protein-containing aqueous liquid formulation (2023-08-29),

10. 11649474 - Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain (2023-05-16),

11. 11634474 - Human serum albumin mutant (2023-04-25),

12. 11512135 - Method for producing antibody fusion protein (2022-11-29),

13. 11248045 - Anti-human transferrin receptor antibody permeating blood-brain barrier (2022-02-15),

14. 11130815 - Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody (2021-09-28),

15. 11111308 - Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier (2021-09-07),

JCR Pharmaceuticals Co., Ltd. is a Japanese biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative pharmaceutical products. They focus on therapeutics for rare diseases and intractable illnesses. With a strong commitment to improving the quality of life for patients, JCR Pharmaceuticals strives to bring advanced medical solutions to global markets.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

80 Patents

#16 in Hyogo

#1,257 in Japan

#9,054 in the World

Jcr Pharmaceuticals Co., Ltd.

Forward Citations = 220

184 inventors:

Kenichi Takahashi (17 out of 17 patents)

Hiroyuki Sonoda (12 out of 12 patents)

Susumu Seino (7 out of 13 patents)

4. Takashi Hanada (6 out of 7 patents)

5. Atsushi Sugimura (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…